BILLIE RAEL: Open Payments
NPI 1134712821 · WATERLOO, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$161 in 8 payments from 6 companies in 2025. Trend: 2023 $134 · 2024 $55 · 2025 $161
Food & beverage: $161
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| Alkermes, Inc. | 1 | $27 |
| ABBVIE INC. | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
| Indivior Inc. | 1 | $14 |
Products named: ARISTADA, REXULTI, ABILIFY ASIMTUFII, VRAYLAR, UZEDY, INVEGA SUSTENNA, AUSTEDO XR, SUBLOCADE.
Industry payments across IA — which companies pay providers there.
